Defined Financial Planning LLC lowered its stake in Oracle Corporation (NYSE:ORCL – Free Report) by 50.4% in the second quarter, HoldingsChannel.com reports. The firm owned 885 shares of the enterprise software provider’s stock after selling 899 shares during the quarter. Defined Financial Planning LLC’s holdings in Oracle were worth $208,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the business. Reyes Financial Architecture Inc. increased its position in Oracle by 7.2% during the second quarter. Reyes Financial Architecture Inc. now owns 643 shares of the enterprise software provider’s stock worth $141,000 after acquiring an additional 43 shares during the period. Creative Capital Management Investments LLC boosted its stake in Oracle by 5.7% in the second quarter. Creative Capital Management Investments LLC now owns 798 shares of the enterprise software provider’s stock valued at $174,000 after buying an additional 43 shares in the last quarter. Davis Investment Partners LLC increased its holdings in shares of Oracle by 0.7% during the second quarter. Davis Investment Partners LLC now owns 6,930 shares of the enterprise software provider’s stock worth $1,517,000 after buying an additional 46 shares in the last quarter. Acropolis Investment Management LLC boosted its stake in shares of Oracle by 2.6% during the second quarter. Acropolis Investment Management LLC now owns 1,850 shares of the enterprise software provider’s stock valued at $404,000 after purchasing an additional 47 shares in the last quarter. Finally, Sunpointe LLC grew its holdings in Oracle by 0.9% during the 2nd quarter. Sunpointe LLC now owns 5,563 shares of the enterprise software provider’s stock worth $1,216,000 after acquiring an additional 48 shares during the last quarter. 42.44% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on ORCL shares. CIBC reissued a “buy” rating on shares of Oracle in a research note on Monday, June 9th. Evercore ISI upped their target price on shares of Oracle from $270.00 to $340.00 and gave the stock an “outperform” rating in a report on Wednesday, September 10th. KeyCorp raised their price objective on Oracle from $200.00 to $225.00 and gave the company an “overweight” rating in a research note on Thursday, June 12th. Oppenheimer restated an “outperform” rating on shares of Oracle in a research note on Wednesday, June 18th. Finally, Citigroup restated an “outperform” rating on shares of Oracle in a research note on Wednesday, September 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $304.71.
Insiders Place Their Bets
In related news, Director William G. Parrett sold 11,500 shares of the business’s stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $306.00, for a total value of $3,519,000.00. Following the transaction, the director directly owned 17,764 shares of the company’s stock, valued at approximately $5,435,784. The trade was a 39.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michael D. Sicilia sold 33,845 shares of Oracle stock in a transaction that occurred on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the sale, the insider owned 132,656 shares in the company, valued at approximately $42,603,800.96. The trade was a 20.33% decrease in their position. The disclosure for this sale can be found here. Insiders sold 104,314 shares of company stock valued at $31,272,223 in the last ninety days. Insiders own 40.90% of the company’s stock.
Oracle Stock Performance
Oracle stock opened at $291.77 on Tuesday. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The stock’s 50 day moving average is $263.41 and its 200 day moving average is $206.82. The company has a market capitalization of $831.77 billion, a P/E ratio of 67.54, a PEG ratio of 3.08 and a beta of 1.53. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33.
Oracle (NYSE:ORCL – Get Free Report) last posted its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. During the same quarter in the prior year, the firm earned $1.39 EPS. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities research analysts predict that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.7%. Oracle’s dividend payout ratio is currently 46.30%.
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More
- Five stocks we like better than Oracle
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- What is a SEC Filing?
- 3 Exceptional Stocks to Build Long-Term Wealth
- Where Do I Find 52-Week Highs and Lows?
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.